Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.

Gwadz MV, Collins LM, Cleland CM, Leonard NR, Wilton L, Gandhi M, Scott Braithwaite R, Perlman DC, Kutnick A, Ritchie AS.

BMC Public Health. 2017 May 4;17(1):383. doi: 10.1186/s12889-017-4279-7.

2.

Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.

Liu P, Dillingham R, McManus K.

AIDS Res Ther. 2017 May 2;14:25. doi: 10.1186/s12981-017-0152-0. eCollection 2017. Erratum in: AIDS Res Ther. 2017 May 22;14 :29.

3.

Capturing the Social Location of African American Mothers Living With HIV: An Inquiry Into How Social Determinants of Health Are Framed.

Caiola C, Barroso J, Docherty SL.

Nurs Res. 2017 May/Jun;66(3):209-221. doi: 10.1097/NNR.0000000000000213.

PMID:
28252555
4.

Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.

Reddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RP.

J Infect Dis. 2016 Dec 1;214(11):1672-1681. Epub 2016 Nov 3.

PMID:
27815384
5.

Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.

Piggott DA, Erlandson KM, Yarasheski KE.

Curr HIV/AIDS Rep. 2016 Dec;13(6):340-348. Review.

PMID:
27549318
6.

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.

Pérez-Santiago J, Ouchi D, Urrea V, Carrillo J, Cabrera C, Villà-Freixa J, Puig J, Paredes R, Negredo E, Clotet B, Massanella M, Blanco J.

AIDS. 2016 Sep 24;30(15):2275-87. doi: 10.1097/QAD.0000000000001205.

7.

Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected Adults.

Önen NF, Patel P, Baker J, Conley L, Brooks JT, Bush T, Henry K, Hammer J, Kojic EM, Overton ET.

J Frailty Aging. 2014;3(3):158-65. doi: 10.14283/jfa.2014.18.

8.

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection.

Grady BP, Nanlohy NM, van Baarle D.

Immun Ageing. 2016 Mar 31;13:10. doi: 10.1186/s12979-016-0065-0. eCollection 2016.

9.

Increasing Antiretroviral Adherence for HIV-Positive African Americans (Project Rise): A Treatment Education Intervention Protocol.

Wagner GJ, Bogart LM, Mutchler MG, McDavitt B, Mutepfa KD, Risley B.

JMIR Res Protoc. 2016 Mar 29;5(1):e45. doi: 10.2196/resprot.5245.

10.

Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS.

Peterson CW, Haworth KG, Burke BP, Polacino P, Norman KK, Adair JE, Hu SL, Bartlett JS, Symonds GP, Kiem HP.

Mol Ther Methods Clin Dev. 2016 Feb 24;3:16007. doi: 10.1038/mtm.2016.7. eCollection 2016.

11.

Racial-ethnic differences in all-cause and HIV mortality, Florida, 2000-2011.

Trepka MJ, Fennie KP, Sheehan DM, Niyonsenga T, Lieb S, Maddox LM.

Ann Epidemiol. 2016 Mar;26(3):176-82.e1. doi: 10.1016/j.annepidem.2016.02.002. Epub 2016 Feb 16.

12.

HIV-Related Mortality Among Adults (≥ 18 years) of Various Hispanic or Latino Subgroups--United States, 2006-2010.

Clark H, Surendera Babu A, Harris S, Hardnett F.

J Racial Ethn Health Disparities. 2015 Mar;2(1):53-61. doi: 10.1007/s40615-014-0047-x. Epub 2014 Oct 2.

13.

Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy.

Del Prete GQ, Oswald K, Lara A, Shoemaker R, Smedley J, Macallister R, Coalter V, Wiles A, Wiles R, Li Y, Fast R, Kiser R, Lu B, Zheng J, Alvord WG, Trubey CM, Piatak M Jr, Deleage C, Keele BF, Estes JD, Hesselgesser J, Geleziunas R, Lifson JD.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1560-72. doi: 10.1128/AAC.02625-15.

14.

Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.

Schackman BR, Haas DW, Park SS, Li XC, Freedberg KA.

Pharmacogenomics. 2015 Dec;16(18):2007-18. doi: 10.2217/pgs.15.142. Epub 2015 Nov 26.

15.

Employing human rights frameworks to realize access to an HIV cure.

Meier BM, Gelpi A, Kavanagh MM, Forman L, Amon JJ.

J Int AIDS Soc. 2015 Nov 13;18:20305. doi: 10.7448/IAS.18.1.20305. eCollection 2015.

16.

Informal HIV Caregiver Proxy Reports of Care Recipients' Treatment Adherence: Relationship Factors Associated with Concordance with Recipients' Viral Suppression.

Knowlton AR, Mitchell MM, Robinson AC, Nguyen TQ, Isenberg S, Denison J.

AIDS Behav. 2015 Nov;19(11):2123-9. doi: 10.1007/s10461-015-1092-0.

17.

Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design.

Kitahata MM, Drozd DR, Crane HM, Van Rompaey SE, Althoff KN, Gange SJ, Klein MB, Lucas GM, Abraham AG, Lo Re V 3rd, McReynolds J, Lober WB, Mendes A, Modur SP, Jing Y, Morton EJ, Griffith MA, Freeman AM, Moore RD.

AIDS Res Treat. 2015;2015:923194. doi: 10.1155/2015/923194. Epub 2015 Feb 19.

18.

In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.

Wildum S, Zimmermann H, Lischka P.

Antimicrob Agents Chemother. 2015;59(6):3140-8. doi: 10.1128/AAC.00114-15. Epub 2015 Mar 16.

19.

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.

Lourenço L, Samji H, Nohpal A, Chau W, Colley G, Lepik K, Barrios R, Lima V, Hogg RS, Montaner J, Kesselring S, Moore DM.

HIV Med. 2015 Jul;16(6):337-45. doi: 10.1111/hiv.12212. Epub 2015 Feb 27.

20.

The lifetime medical cost savings from preventing HIV in the United States.

Schackman BR, Fleishman JA, Su AE, Berkowitz BK, Moore RD, Walensky RP, Becker JE, Voss C, Paltiel AD, Weinstein MC, Freedberg KA, Gebo KA, Losina E.

Med Care. 2015 Apr;53(4):293-301. doi: 10.1097/MLR.0000000000000308.

Supplemental Content

Support Center